These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 28802832)
1. Retroviral gene transfer into primary human NK cells activated by IL-2 and K562 feeder cells expressing membrane-bound IL-21. Streltsova MA; Barsov E; Erokhina SA; Kovalenko EI J Immunol Methods; 2017 Nov; 450():90-94. PubMed ID: 28802832 [TBL] [Abstract][Full Text] [Related]
2. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells. Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809 [TBL] [Abstract][Full Text] [Related]
3. Recurrent Stimulation of Natural Killer Cell Clones with K562 Expressing Membrane-Bound Interleukin-21 Affects Their Phenotype, Interferon-γ Production, and Lifespan. Streltsova MA; Erokhina SA; Kanevskiy LM; Grechikhina MV; Kobyzeva PA; Lee DA; Telford WG; Sapozhnikov AM; Kovalenko EI Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669565 [TBL] [Abstract][Full Text] [Related]
5. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659 [TBL] [Abstract][Full Text] [Related]
6. Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2A. Streltsova MA; Erokhina SA; Kanevskiy LM; Lee DA; Telford WG; Sapozhnikov AM; Kovalenko EI PLoS One; 2018; 13(12):e0208469. PubMed ID: 30517188 [TBL] [Abstract][Full Text] [Related]
7. Gene Modification of Human Natural Killer Cells Using a Retroviral Vector. Kellner JN; Cruz CR; Bollard CM; Yvon ES Methods Mol Biol; 2016; 1441():203-13. PubMed ID: 27177668 [TBL] [Abstract][Full Text] [Related]
8. Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21. Kweon S; Phan MT; Chun S; Yu H; Kim J; Kim S; Lee J; Ali AK; Lee SH; Kim SK; Doh J; Cho D Front Immunol; 2019; 10():879. PubMed ID: 31105701 [No Abstract] [Full Text] [Related]
9. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Jiang B; Wu X; Li XN; Yang X; Zhou Y; Yan H; Wei AH; Yan W Cell Immunol; 2014 Jul; 290(1):10-20. PubMed ID: 24859012 [TBL] [Abstract][Full Text] [Related]
10. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21. Thangaraj JL; Phan MT; Kweon S; Kim J; Lee JM; Hwang I; Park J; Doh J; Lee SH; Vo MC; Chu TH; Song GY; Ahn SY; Jung SH; Kim HJ; Cho D; Lee JJ Cancer Immunol Immunother; 2022 Mar; 71(3):613-625. PubMed ID: 34282497 [TBL] [Abstract][Full Text] [Related]
11. Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors. Hromadnikova I; Pirkova P; Sedlackova L Mediators Inflamm; 2013; 2013():405295. PubMed ID: 23476104 [TBL] [Abstract][Full Text] [Related]
12. Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. Denman CJ; Senyukov VV; Somanchi SS; Phatarpekar PV; Kopp LM; Johnson JL; Singh H; Hurton L; Maiti SN; Huls MH; Champlin RE; Cooper LJ; Lee DA PLoS One; 2012; 7(1):e30264. PubMed ID: 22279576 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells. Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077 [TBL] [Abstract][Full Text] [Related]
15. An Experimental Study Comparing the Expansion of Peripheral Blood Natural Killer (NK) Cells Cultured with Artificial Antigen-Presenting Cells, in the Presence or Absence of Bone Marrow Mesenchymal Stem Cells (MSCs). Pedroso JF; de Souza Valim V; Pezzi A; Furlan JM; Lenhart G; Sehn F; Zambonato B; Gonçalves AD; Wilke I; Amorin B; da Silva MA; Pedrazzani FS; da Rocha Silla LM Mol Biotechnol; 2020 May; 62(5):306-315. PubMed ID: 32193710 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum-free media formulations in feeder cell-stimulated expansion of natural killer cells. Moseman JE; Foltz JA; Sorathia K; Heipertz EL; Lee DA Cytotherapy; 2020 Jun; 22(6):322-328. PubMed ID: 32278551 [TBL] [Abstract][Full Text] [Related]
17. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells. Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581 [TBL] [Abstract][Full Text] [Related]
18. Ex Vivo Expansion of Human NK Cells Using K562 Engineered to Express Membrane Bound IL21. Somanchi SS; Lee DA Methods Mol Biol; 2016; 1441():175-93. PubMed ID: 27177666 [TBL] [Abstract][Full Text] [Related]
19. Human natural killer cells expressing the memory-associated marker CD45RO from tuberculous pleurisy respond more strongly and rapidly than CD45RO- natural killer cells following stimulation with interleukin-12. Fu X; Liu Y; Li L; Li Q; Qiao D; Wang H; Lao S; Fan Y; Wu C Immunology; 2011 Sep; 134(1):41-9. PubMed ID: 21711347 [TBL] [Abstract][Full Text] [Related]
20. Increased Susceptibility of the CD57 Palamarchuk AI; Alekseeva NA; Streltsova MA; Ustiuzhanina MO; Kobyzeva PA; Kust SA; Grechikhina MV; Boyko AA; Shustova OA; Sapozhnikov AM; Kovalenko EI Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]